Changchun High-Tech: Jinbeixin Achieves Strong Sales Since Mid-July Launch After June 2025 Approval

Deep News

Oct 31, 2025

Changchun High-Tech Industry (Group) Co., Ltd. announced on October 31 that Jinbeixin, approved in late June 2025, commenced sales in mid-July and has demonstrated robust performance. The product generated over CNY 55 million in revenue during Q3 2025. The company has established a 200-member sales team and is rapidly expanding hospital and channel coverage.

For Mesia, targeting cancer-related anorexia-cachexia, promotional efforts over the past year have driven sales close to CNY 100 million in the first three quarters of 2025. The company plans to enhance promotion further, aligning with national medical insurance negotiations to boost awareness among hospitals, doctors, and patients.

Moving forward, Changchun High-Tech will focus resources on high-potential new products to diversify its business and drive growth.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1126490787"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1126490787\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1126490787?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-10-31 17:30","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1126490787","market":"nz","top_or_hot":-1,"title":"Changchun High-Tech: Jinbeixin Achieves Strong Sales Since Mid-July Launch After June 2025 Approval","media":"Deep News","content":"<p>Changchun High-Tech Industry (Group) Co., Ltd. announced on October 31 that Jinbeixin, approved in late June 2025, commenced sales in mid-July and has demonstrated robust performance. The product generated over CNY 55 million in revenue during Q3 2025. The company has established a 200-member sales team and is rapidly expanding hospital and channel coverage.</p>\n<p>For Mesia, targeting cancer-related anorexia-cachexia, promotional efforts over the past year have driven sales close to CNY 100 million in the first three quarters of 2025. The company plans to enhance promotion further, aligning with national medical insurance negotiations to boost awareness among hospitals, doctors, and patients.</p>\n<p>Moving forward, Changchun High-Tech will focus resources on high-potential new products to diversify its business and drive growth.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Changchun High-Tech: Jinbeixin Achieves Strong Sales Since Mid-July Launch After June 2025 Approval</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nChangchun High-Tech: Jinbeixin Achieves Strong Sales Since Mid-July Launch After June 2025 Approval\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1039043262\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/8296859682db4b478146245e72de1922);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Deep News </p>\n<p class=\"h-time\">2025-10-31 17:30</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Changchun High-Tech Industry (Group) Co., Ltd. announced on October 31 that Jinbeixin, approved in late June 2025, commenced sales in mid-July and has demonstrated robust performance. The product generated over CNY 55 million in revenue during Q3 2025. The company has established a 200-member sales team and is rapidly expanding hospital and channel coverage.</p>\n<p>For Mesia, targeting cancer-related anorexia-cachexia, promotional efforts over the past year have driven sales close to CNY 100 million in the first three quarters of 2025. The company plans to enhance promotion further, aligning with national medical insurance negotiations to boost awareness among hospitals, doctors, and patients.</p>\n<p>Moving forward, Changchun High-Tech will focus resources on high-potential new products to diversify its business and drive growth.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK0075","symbol_name":"新三板","start_time":0,"source_url":"","article_id":"1126490787","we_media_id":"1039043262","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1126490787","pubTimestamp":1761903032,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Deep News","introduction":"Global Stock Market Deep Analysis","home_visible":1,"id":"1039043262","head_image":"https://community-static.tradeup.com/news/8296859682db4b478146245e72de1922"},"summary":"Changchun High-Tech Industry (Group) Co., Ltd. announced on October 31 that Jinbeixin, approved in late June 2025, commenced sales in mid-July and has demonstrated robust performance. The product...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK0075":"新三板","BK0188":"融资融券","BK0028":"国家队","BK0046":"生物疫苗","000661":"长春高新","BK0057":"长吉图板块","BK0239":"医药制造"},"translate_title":"长春高新：金贝芯2025年6月获批后7月中旬上市以来实现强劲销售","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"91272":1,"000661":1},"content_text":"Changchun High-Tech Industry (Group) Co., Ltd. announced on October 31 that Jinbeixin, approved in late June 2025, commenced sales in mid-July and has demonstrated robust performance. The product generated over CNY 55 million in revenue during Q3 2025. The company has established a 200-member sales team and is rapidly expanding hospital and channel coverage.\nFor Mesia, targeting cancer-related anorexia-cachexia, promotional efforts over the past year have driven sales close to CNY 100 million in the first three quarters of 2025. The company plans to enhance promotion further, aligning with national medical insurance negotiations to boost awareness among hospitals, doctors, and patients.\nMoving forward, Changchun High-Tech will focus resources on high-potential new products to diversify its business and drive growth.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"dataReport","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}